Compare Cardinal Health Inc (CAH) vs Modine Manufacturing Company (MOD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Modine Manufacturing Company — how do they compare? Cardinal Health Inc trades at $228.8 (market cap $53.89B), while Modine Manufacturing Company trades at $230.32 (market cap $12.19B). The key difference: Cardinal Health Inc is far larger — about 4.4× Modine Manufacturing Company's market cap, and Cardinal Health Inc pays a 0.89% dividend while Modine Manufacturing Company pays none. Which is the better fit depends on your goals.
| CAH | MOD | |
|---|---|---|
Market Cap | $53.89B | $12.19B |
Sector | Health | Technology |
52-Week High | $239.71 | $306.89 |
52-Week Low | $146.04 | $90.02 |
Enterprise Value | $58.87B | $12.55B |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
Modine (MOD) is trading at $234.28, down 4.73% amid bearish technical signals, though it maintains strong analyst support with a $328.80 consensus price target. The company has consistently beaten earnings expectations in recent quarters, with Q1 2026 EPS of $1.71 exceeding estimates by 10%. Fundamentals show revenue growth to $2.58 billion in 2025 but declining net margins, while the stock trades at elevated valuation multiples including a P/E of 101.58.
The outlook remains positive based on analyst consensus and recent executive appointments, but risks include high valuation, margin pressure, and technical weakness. Investment opportunity lies in the 40% upside to price targets if execution continues, though investors face volatility from supply chain challenges and competitive pressures in the thermal management sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Modine Manufacturing Company
Modine Manufacturing Company is a global leader in thermal management technology and solutions. The company engineers, manufactures, and markets heat transfer products for a wide range of applications across the automotive, commercial, industrial, and HVAC (heating, ventilation, and air conditioning) markets. Modine's products include engine cooling systems, heat exchangers, and ventilation systems, providing critical thermal solutions for vehicles, data centers, and various equipment worldwide.
Read more on MOD →
